Version 1
: Received: 20 March 2020 / Approved: 23 March 2020 / Online: 23 March 2020 (00:33:02 CET)
How to cite:
Doss, M. Treatment of COVID-19 with Individualized Immune Boosting Interventions. Preprints2020, 2020030319. https://doi.org/10.20944/preprints202003.0319.v1
Doss, M. Treatment of COVID-19 with Individualized Immune Boosting Interventions. Preprints 2020, 2020030319. https://doi.org/10.20944/preprints202003.0319.v1
Doss, M. Treatment of COVID-19 with Individualized Immune Boosting Interventions. Preprints2020, 2020030319. https://doi.org/10.20944/preprints202003.0319.v1
APA Style
Doss, M. (2020). <em></em>Treatment of COVID-19 with Individualized Immune Boosting Interventions. Preprints. https://doi.org/10.20944/preprints202003.0319.v1
Chicago/Turabian Style
Doss, M. 2020 "<em></em>Treatment of COVID-19 with Individualized Immune Boosting Interventions" Preprints. https://doi.org/10.20944/preprints202003.0319.v1
Abstract
The current global pandemic of coronavirus disease 2019 (COVID-19) caused by the coronavirus SARS-CoV-2 has already had a major adverse impact on the world due to the exponentially increasing deaths due to the disease and the extreme actions taken by the world community to prevent its spread. It is important to explore novel methods of reducing the illnesses and fatality rates of the coronavirus-infected patients. Since the weakness of the immune system is one of the major contributing factors for the illnesses caused by such viruses, and since inflammation is a major contributing factor for the mortality of COVID-19 patients, interventions that boost the immune system and/or are anti-inflammatory may reduce the COVID-19 incidence and the mortality due to the disease. A large variety of interventions are known to improve the immune response and/or reduce inflammation. However, all the interventions would not be applicable or acceptable to everyone and so the interventions would need to be individualized based on individual circumstances and preferences. This approach, known as “Individualized Interventions to Improve the Immune Response”, or the I4R approach, should be studied in pilot clinical trials urgently, in order to potentially reduce the harm caused by the current coronavirus pandemic.
Medicine and Pharmacology, Pulmonary and Respiratory Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
